Patents by Inventor Tim Vanuytsel

Tim Vanuytsel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12551516
    Abstract: The present invention relates to a composition comprising L. rhamnosus CNCM I-3690 for use in prevention, amelioration or treatment of anxiety and/or psychological stress in an individual.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: February 17, 2026
    Assignee: COMPAGNIE GERVAIS DANONE
    Inventors: Tamara Smokvina, Raphaël Moriez, Jan Tack, Lukas Van Oudenhove, Tim Vanuytsel, Lucas Wauters
  • Patent number: 12414970
    Abstract: The invention in general relates to the use of probiotics for the management of functional gastrointestinal disorders. More specifically, the present invention relates to the use of Bacillus coagulans or Bacillus subtilis or a combination of both strains for the prevention or treatment of functional gastrointestinal disorders, such as for example functional dyspepsia. The present invention also discloses the use of Bacillus coagulans or Bacillus subtilis or a combination of both strains as alternative therapy or adjunct therapy for or gastric acid suppression treatment.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: September 16, 2025
    Assignee: My Health International
    Inventors: Raf Dybajlo, Wannes Thys, Lucas Wauters, Tim Vanuytsel
  • Publication number: 20220241357
    Abstract: The present invention relates to a composition comprising L. rhamnosus CNCM I-3690 for use in prevention, amelioration or treatment of anxiety and/or psychological stress in an individual.
    Type: Application
    Filed: June 12, 2020
    Publication date: August 4, 2022
    Inventors: Tamara SMOKVINA, Raphaël MORIEZ, Jan TACK, Lukas VAN OUDENHOVE, Tim VANUYTSEL, Lucas WAUTERS
  • Publication number: 20220160793
    Abstract: The invention in general relates to the use of probiotics for the management of functional gastrointestinal disorders. More specifically, the present invention relates to the use of Bacillus coagulans or Bacillus subtilis or a combination of both strains for the prevention or treatment of functional gastrointestinal disorders, such as for example functional dyspepsia. The present invention also discloses the use of Bacillus coagulans or Bacillus subtilis or a combination of both strains as alternative therapy or adjunct therapy for or gastric acid suppression treatment.
    Type: Application
    Filed: March 27, 2020
    Publication date: May 26, 2022
    Applicant: MY RESEARCH
    Inventors: Raf Dybajlo, Wannes Thys, Lucas Wauters, Tim Vanuytsel